Skip to main content

Decadron News

High-Dose Glucocorticoids No Better Than Low-Dose for Sudden Hearing Loss

WEDNESDAY, Jan. 10, 2024 – For patients with idiopathic sudden sensorineural hearing loss (ISSNHL), systemic high-dose glucocorticoid therapy is no better than a lower-dose regimen, according to a...

Dexamethasone No Benefit in HIV-Positive With Tuberculous Meningitis

THURSDAY, Oct. 12, 2023 – For HIV-positive adults with tuberculous meningitis, adjunctive dexamethasone does not confer a benefit with respect to survival, according to a study published in the Oct....

Could Cold Air Help Settle a Case of Croup? New Study Says Yes

TUESDAY, Aug. 1, 2023 – Pediatricians have suspected it for years, and now a new study may be proving them right: Cold air really can help ease children's croup symptoms. Croup is a common childhood...

Exposure to Outdoor Cold Air Beneficial for Children With Croup

TUESDAY, Aug. 1, 2023 – A 30-minute exposure to outdoor cold air is beneficial for reducing clinical symptoms in children with croup as an adjunct to oral dexamethasone, according to a study...

FDA Medwatch Alert: FDA Warns Consumers Not to Purchase or Use Artri and Ortiga Products, Which May Contain Hidden Drug Ingredients

April 20, 2021 --FDA is warning consumers not to purchase or use products marketed with variations of the names “Artri” or “Ortiga” due to potentially dangerous hidden active drug ingredients not list...

FDA Medwatch Alert: Edge Pharma, LLC Issues Voluntary Nationwide Recall of All Drug Products Due to Lack of Sterility Assurance

December 4, 2021 – Colchester, VT, Edge Pharma, LLC is voluntarily recalling all lots of all drugs compounded at Edge Pharma, LLC to the consumer level. All products are being recalled due to process ...

FDA Medwatch Alert: Epidural Corticosteroid Injection: Drug Safety Communication - Risk of Rare But Serious Neurologic Problems

Including methylprednisolone, hydrocortisone, triamcinolone, betamethasone, and dexamethasone [Posted 04/23/2014] ISSUE: FDA is warning that injection of corticosteroids into the epidural space of...

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

Reumofan Plus USA, LLC and Reumofan USA, LLC is recalling "Reumofan Plus" Tablets, Lot# 99515, exp. 09/16, because they contain undeclared active pharmaceutical ingredients: methocarbamol,...

FDA Medwatch Alert: Reumofan Plus Dietary Supplement Relabeled and Sold as “WOW”: Public Warning - Undeclared Drug Ingredients

ISSUE: The U.S. Food and Drug Administration (FDA) is warning the public that the potentially harmful dietary supplement product Reumofan Plus is being relabeled and sold under the name “WOW.”  The pr...

FDA Medwatch Alert: Reumofan Plus: Recall - Undeclared Drug Ingredient

ISSUE: FDA is warning consumers that Reumofan Plus, marketed as a natural dietary supplement for pain relief and other serious conditions, contains several active pharmaceutical ingredients not...

FDA Medwatch Alert: American Regent Injectable Products: Recall - Visible Particulates in Products

Methyldopate HCL Injection, USP 5ml Single Dose Vial Caffeine & Sodium Benzoate Injection, USP, 250 mg/mL, 2 mL Single Dose Vial Ammonium Molybdate Injection, USP (Molybdenum 250mcg/10 mL) 10 mL...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Multiple Myeloma, Leukemia, Systemic Lupus Erythematosus, Lymphoma, Multiple Sclerosis, Nausea / Vomiting - Chemotherapy Induced, Ulcerative Colitis, Psoriatic Arthritis, Rheumatoid Arthritis, view more... Seborrheic Dermatitis, Shock, Juvenile Rheumatoid Arthritis, Hay Fever, Allergic Rhinitis, Ankylosing Spondylitis, Asthma, Asthma - Acute, Contact Dermatitis, Atopic Dermatitis, Bursitis, Eczema, Inflammatory Bowel Disease, Inflammatory Conditions

Decadron patient information at Drugs.com